The Supreme Court goes right up to its deadline and finally weighs in on the widely used abortion pill mifepristone. The court ruling preserves access to the drug and declines restrictions on its use as the lawsuit over its FDA approval continues. The panel discusses how this case and the overall debate over abortion rights will play in the 2024 campaign.